Myrbetriq is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Image of 3 Ingredient Peanut Butter Cookies

3 Ingredient Peanut Butter Cookies

Prep: 10 minutes
Cook: 10 minutes
Serves: 24

Image of a cup of peanut butter

Ingredients

  • 1 cup smooth peanut butter
  • 1 cup light brown sugar
  • 1 large egg

Directions

  1. Preheat oven to 350°F. Line a baking sheet with parchment paper.
  2. Mix together peanut butter, sugar and egg in a medium bowl using an electric mixer, and mix until smooth.
  3. Roll tablespoon-sized dough into balls and arrange on the baking sheet, leaving 2-inch spaces between each cookie. Press each cookie down with the back of a fork to create a crisscross pattern.
  4. Bake for 8 to 10 minutes, or until edges are lightly browned. Remove from the oven and allow to cool for 5 minutes on the hot sheet pan before transferring to a wire rack to cool completely.
Image of nutrition information for 3 Ingredient Peanut Butter Cookies including serving size of 22 grams, 24 servings per recipe with 1 cookie per serving, and 100 calories per serving.
Image of nutrition information for 3 Ingredient Peanut Butter Cookies including serving size of 22 grams, 24 servings per recipe with 1 cookie per serving, and 100 calories per serving.

You May Also Like

Use of Myrbetriq


MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream. MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Use of Myrbetriq


MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream. MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.